Health Care & Life Sciences » Biotechnology | Factor Therapeutics Ltd.

Factor Therapeutics Ltd. | Income Statement

Fiscal year is January-December. All values AUD Thousands.
2013
2014
2015
2016
2017
2018
Cost of Goods Sold (COGS) incl. D&A
2,860.20
83.50
80.70
42.70
1,766.00
47.30
Gross Income
2,860.20
83.50
80.70
42.70
1,766.00
47.30
SG&A Expense
3,163.70
6,831.80
7,215.20
4,397.10
6,763.20
10,743.40
EBIT
6,236.10
-
11,387.70
11,950.60
8,529.20
10,790.70
Unusual Expense
-
67.90
67.90
7,485.70
-
557.30
Non Operating Income/Expense
1.10
579.50
276.50
206.40
411.70
282.80
Pretax Income
6,051.10
7,333.60
11,561.00
12,045.60
8,915.70
11,009.70
Income Tax
311.00
504.00
342.50
433.60
3,040.00
53.70
Consolidated Net Income
5,740.10
6,829.60
11,218.50
11,612.00
5,875.70
10,956
Net Income
5,740.10
6,829.60
11,218.50
11,612.00
5,875.70
10,956
Net Income After Extraordinaries
5,740.10
6,829.60
11,218.50
11,612.00
5,875.70
10,956
Net Income Available to Common
5,740.10
6,829.60
11,218.50
11,612.00
5,875.70
10,956
EPS (Basic)
0.03
0.03
0.04
0.03
0.01
0.01
Basic Shares Outstanding
198,747.20
256,301.70
291,166.70
384,742.00
736,465.40
803,476.40
EPS (Diluted)
0.03
0.03
0.04
0.03
0.01
0.01
Diluted Shares Outstanding
198,747.20
256,301.70
291,166.70
384,742.00
736,465.40
803,476.40
EBITDA
6,153.10
6,831.80
11,307.00
11,907.90
8,487.30
10,743.40
Other Operating Expense
212.20
-
4,091.80
7,510.80
-
-
Non-Operating Interest Income
186.10
229.10
171.10
111.30
25.10
55.40

About Factor Therapeutics

View Profile
Address
66 Eagle Street
Brisbane Queensland (QLD) 4001
Australia
Employees -
Website http://www.factor-therapeutics.com
Updated 07/08/2019
Factor Therapeutics Ltd. engages in biotechnology and pharmaceutical businesses. It involves in the development and commercialization of wound care therapeutics. It offers treatment for venous leg ulcers and diabetic foot ulcers.